CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Grant or award Director acquired 3,268 shares (grant or award)
- 4 Grant or award CEO acquired 13,072 shares (grant or award)
- 4 Open-market buy 10% owner bought 28,500 shares
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 9,493 shares at $2.42 ($22,973)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President & CEO bought 2,400 shares
- 4/A Grant or award Director acquired 13,252 shares (grant or award)
- 4/A Grant or award Director acquired 7,045 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Secretary & General Counsel sold 980 shares at $3.37 ($3,303)
- 4 Open-market buy President & CEO bought 5,000 shares at $3.36 ($16,800)
- 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
- 4 Grant or award Secretary & General Counsel acquired 10,000 shares (grant or award)
Page 5 of 28 · 551 filings